ALKS
Alkermes plc
NASDAQ · IEHealthcareBiotechnology
$51.72-1.90%
Price as of Jul 20, 2026
ALKS profitability
Alkermes plc profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 86.6%
- EBITDA margin
- 17.7%
- EBIT margin
- 12.3%
- Net margin
- 9.8%
- Free cash flow margin
- 14.2%
Returns
- Return on equity
- 8.7%
- Return on assets
- 3.6%
- Return on invested capital
- 5.8%
- Asset turnover
- 0.46x
Cash efficiency
- Cash from operations
- $256.2M
- Cash per share
- $3.07
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.